University of Pittsburgh School of Pharmacy

The Class of 2025 is off to an incredible start, with 40 students matching into residency programs across 14 states! ?? Plus, 26 PGY1 residents from the Class of 2024 are continuing their journeys by matching into PGY2 programs. ?? We are so proud of your hard work and dedication—congratulations! #pittpharmacy #h2p

The American Pharmacists Association (APhA) Annual Conference 2025 was a huge success! ?? Pitt Pharmacy showed up in a big way in Nashville! ???? ? Student Awards: ?? Chapter Advocacy Award – Anneliese Harp (‘23-24 Vice President of Policy) and Julia Lazzaris (‘23-24 Vice President of Policy Elect). Pictured: Olivia Frey & Kayleigh Moyer ?? Operation Substance Use Disorder National Runner-Up ?? Presentations: ?? Ravi Patel, Lucas Berenbrok, PharmD, MS, BCACP, FAPhA, & Erin Austin ?? Alumni Recognition: ??? Heather Johnson & Gretchen Garofoli ?? Dr. Melissa Somma McGivney proudly served on the APhA Board of Trustees! ? Plus, 10+ poster presentations showcasing incredible research! Congrats to all who made this event unforgettable! ???? #PittPharmacy #APhA2025 #h2p

Join us in celebrating our graduating PharmD students who have accepted fellowships!??Their hard work and dedication are paving the way for the future of pharmacy. H2P! ?? #pittpharmacy #h2p

??Pitt Pharmacy graduates had a 85.7% NAPLEX first time pass rate for the PharmD Class of 2024 compared to the national average of 77.5%. Our new grads had a MPJE first time pass rate of 93.5% compared to the national average of 76.6%. Proud of you, #PittPharmacy Panthers! Congratulations! ?? #H2P #naplex #mpje

A special day for PittPharmacy! Our P2 class met with Walgreens leaders…who are Pitt alumni! ?? Thanks to: ??Mike Umbleby (PHARM ‘96) ??Darem Dughri Dughri (PHARM ‘06) ??Ashley Patrick, PharmD (PHARM ‘19) ??John Colaizzi, Jr, PharmD, FNJPhA Group Vice President, Head of Enterprise Pharmacy Practice This is a part of our P2 CLIP Workshop series held each spring. We were also joined by Pittsburgh area community pharmacy leaders from Value Drug Company, Giant Eagle, Rite Aid, CVS and Walgreens who met with our P2 class during lunch at our CLIP Workshop today. Shout out to all our colleagues supporting our students and serving our community!?? #h2p #pittpharmacy

Huge thanks to team Walgreens for hosting Pitt Pharmacy at their new Gene and Cell Therapy Pharmacy here in Pittsburgh and for visiting Pitt!? Also pictured: our Pitt Vaccination and Health Connection Hub team, and lunch with students. Moving pharmacy forward together is our collective goal! #pittpharmacy #h2p ??

Congratulations?to Dr. Andrew Haddad for successfully defending his PhD dissertation! #H2P??

Great News! ??? Our application deadline has been extended! Thinking about your future in pharmacy? There’s still time to apply!??We’ve extended our PharmCAS application deadline to April 1st, giving you more time to take the next step towards earning your PharmD at Pitt Pharmacy. ??More time to apply ??More time to explore ??More time to start your journey with us! Still have questions? Our faculty and students are happy to share why Pitt Pharmacy could be the perfect place for you. Contact the Pitt Pharmacy PharmD Admissions Team at: [email protected] or 412-383-9000. Don’t miss this opportunity – apply today! ??https://lnkd.in/guAyv6RF #pittpharmacy #h2p

Mark your calendars! ?? The 68th Annual Dr. Julius A. Koch lecture is at 12pm on April 2, 2025 in 3785 Scaife Hall. We hope you join us!? #pittpharmacy #h2p

Happy 36th Birthday to Tacrolimus! ?? It was in March of 1989 that the first patient received FK506—now known as tacrolimus—intravenously, forever changing the future of organ transplantation. All of this was possible because of the vision, leadership, and perseverance of pioneering transplant surgeon, Dr. Thomas Starzl. He commanded an army of healthcare professionals and administrative staff with the support of the University of Pittsburgh and University of Pittsburgh Medical Center. Pitt Pharmacy faculty members played a key role in developing safe and effective dosage regimens for this groundbreaking drug in collaboration Dr. Starzl. Today, tacrolimus is used in over 90% of transplant patients worldwide, saving countless lives. Our own Dr. Raman Venkataramanan, a critical leader of this work, reflected back to “thank all the patients who participated in the early studies, and all the healthcare personnel and administrative staff of the University who worked tirelessly to make this possible.” Join us in celebrating this incredible milestone and honoring the patients, researchers, and healthcare professionals who made it possible! ?? #PittPharmacy #h2p